This inventor holds 1 USPTO granted patent and 2 EPO patents. Top assignee: Lek Pharmaceuticals D.d.. Active years: 2012.
Company Filing History:
Years Active: 2012
Title: The Innovative Contributions of Janez Rzen
Introduction
Janez Rzen is a notable inventor based in Ljubljana, Slovenia. He has made significant contributions to the pharmaceutical industry, particularly through his innovative work on omeprazole sodium. His research and inventions have the potential to improve treatments for gastrointestinal disorders.
Latest Patents
Janez Rzen holds a patent for a crystalline solvate of omeprazole sodium. This invention relates to a novel crystalline omeprazole sodium ethanol solvate and the process for its preparation. It serves as an intermediary compound for converting into different crystalline forms, specifically omeprazole sodium form A, which has a low amount of residual solvents, less than 0.5% by weight. Additionally, his patent includes novel crystalline forms E and F, both of which also exhibit low levels of residual solvents. These forms are beneficial for treating gastrointestinal disorders.
Career Highlights
Throughout his career, Janez Rzen has worked with prominent companies in the pharmaceutical sector. He has been associated with Lek Pharmaceuticals D.d. and Krka, Tovarna Zdravil D.d. Novo Mesto. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.
Collaborations
Janez Rzen has collaborated with several professionals in his field, including Lidija Vranicar Savanovic and Zoran Ham. These collaborations have likely enhanced his research and development efforts.
Conclusion
Janez Rzen's contributions to the pharmaceutical industry through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to impact the treatment of gastrointestinal disorders positively.